HCA Healthcare, Inc.

HCA · Healthcare · · USD

405.00 USD

0.00 (-1.03%)

● Updated 2026-09-07 19:34 Saudi Time ↻ Refresh

Short-term Mid-term Long-term

Fahodi Score SELL Short-term (Swing)

/ 100

Technical 25

Trend & RS 49

Momentum 40

Fundamental (0%) 44

Macro 64

Liquidity 47

Component	Score	Weight
Technical	25.0	40%
Trend & RS	48.6	20%
Momentum	39.7	20%
Fundamental	44.4	0%
Macro	64.4	15%
Liquidity	46.6	5%

Trade Setup

Entry	405.00
Stop Loss	380.84 (6.0%)
Target 1 (1:1)	429.16 (+6.0%)
Target 2 (2:1)	453.32 (+11.9%)

ATR(14)	12.08 (3.0%)
Risk per Share	24.16
Reward:Risk	2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor	Score	Z
Value	80.9	+1.24
Momentum	39.7	-0.41
Quality	25.8	-0.97
Composite	48.8

Quality Scores

Piotroski F-Score 4 /9 — Average

✓ ✗ ✗ ✗ ✗ ✗ ✓ ✓ ✓

1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover

Altman Z-Score Insufficient Data

Valuation vs Peers Undervalued

Metric	Stock	Sector	vs Peers
P/E Ratio	13.6	22.0	-38% below
P/B Ratio	-13.3	4.0	Inline
Dividend Yield	77.0%	1.5%	Above avg

Comparing against Healthcare median multiples.

Trading at a discount to sector peers — potential value opportunity.

Intrinsic Value (DCF) Undervalued

Intrinsic Value

489.18

Market Price

405.00

Upside

+20.8%

Margin of Safety	+17.2%
Stage 1 PV (5yr FCF)	25,603,264,416
Terminal Value PV	80,304,270,123
Total Enterprise Value	105,907,534,539

Assumptions

Base FCF	5,163,128,094
Growth Rate (5yr)	8.7%
Terminal Growth	2.5%
Discount Rate (WACC)	9.0%

2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.

Position Sizing — Kelly Criterion

4.5%

Recommended Size

24.43%

Full Kelly

12.21%

Half Kelly

5.0%

Max Cap (Moderate)

Kelly inputs derived from quant score 40/100. Estimated win rate 52%, avg win 7.4%, avg loss 4.2%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

BEAR Regime: BEAR (20% confidence) — position size reduced 10%

Signal Summary STRONG SELL

Bullish Signals

Bearish Signals

46.44

RSI(14)

2.0734

MACD

Relative Strength (RS) NEUTRAL

/ 99

RS Rating

O'Neil filter: <80

RS vs SPY	→ FLAT (+4.4% vs SPY 3M)
RS vs Sector	INLINE (Healthcare)
RS New High	No (43d since high)
Sector Outperformance	+1.3% (3M)

RS Line — stock / SPY (90 bars)

← older newer →

RS vs SPY 50-day SMA of RS

NEUTRAL: In line with the market — no strong outperformance or underperformance.

Technical Indicators

Indicator	Value	Signal
Rsi	46.44	NEUTRAL
Macd	2.0734	BEARISH
Ma Cross	402.88 / 450.96	DEATH CROSS
Trend Short		ABOVE SMA50
Trend Long		BELOW SMA200
Bollinger		MIDDLE
Volume	0.8x	NORMAL

Key Levels

Level	Price
52-Week High	556.52
Bollinger Upper	431.51
SMA(200)	450.96
SMA(50)	402.88
SMA(20)	414.12
Current Price	405.00
Bollinger Lower	396.72
52-Week Low	353.99
ATR(14)	12.08

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

Insufficient data for Wyckoff analysis.

Volume Spread Analysis (last 5 bars)

Date	Signal	Vol	Description
2026-08-31	Normal	1.08x	Normal bar — no special VSA pattern
2026-09-01	Normal	1.04x	Normal bar — no special VSA pattern
2026-09-02	Normal	1.27x	Normal bar — no special VSA pattern
2026-09-03	Normal	1.13x	Normal bar — no special VSA pattern
2026-09-04	Normal	0.8x	Normal bar — no special VSA pattern

Ichimoku Cloud NEUTRAL

Line	Value	Status
Tenkan-sen (9)	415.13	Above Kijun
Kijun-sen (26)	413.94	Base line
Senkou A	414.54	Leading span A
Senkou B	395.25	Leading span B
Cloud	395.25 – 414.54	Bullish (Green)
Price vs Cloud	405.00	Inside Cloud
Chikou Span	402.59	Bullish
Alignment Score	3/4	NEUTRAL